Oncidium foundation established a partnership with Hackapower Oficial to advance radiotheranostics.
Published
Signal category
Partnerships
Quote
“We're glad about our partnership with Hackapower Oficial”
— Oncidium foundation team
Company
Oncidium foundation
Promote, support and accelerate the development of radiotheranostics for cancer care, worldwide.
- Industry
- Non-profit Organizations
- Location
- Brussels, BE
- Company size
- 66 employees
The Oncidium foundation was created in 2011 to promote the development of nuclear medicine therapy through the dissemination of reliable and complete information for patients. Radiotherapeutics and radiotheranostics represent a new class of drugs that can be used for patient suffering from incurable cancers. The Foundation's priority include promoting the awareness among patients and physicians, investing in research and scholarship, supporting and financing the development of new radiopharmaceuticals for therapy, supporting clinical best practice and improving access to patients.
Founded 2011